RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-793
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0214400; Gene model (P.falciparum): PF3D7_0730300; Gene product: AP2 domain transcription factor AP2-L, putative (AP2-L; ApiAP2)
Name tag: GFP
Phenotype Asexual bloodstage; Oocyst; Sporozoite; Liver stage;
Last modified: 6 February 2013, 09:28
  *RMgm-793
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 23144823
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherS. Iwanaga; M. Yuda
Name Group/DepartmentDepartment of Medical Zoology
Name InstituteMie University School of Medicine
CityTsu, Mie
CountryJapan
Name of the mutant parasite
RMgm numberRMgm-793
Principal nameAP2-L::GFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageAP2-L in the nucleus of erythrocytic trophozoites
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystAP2-L in the nucleus of sporozoites in 10 day old oocysts
SporozoiteAP2-L in the nucleus of sporozoites in 10 day old oocysts and in salivary gland sporozoites
Liver stageAP2-L in the nucleus of liver stages
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of AP2-L (transcription factor with AP2 domain(s))

Protein (function)
Apetala 2 (AP2)-family proteins are transcription factors that have DNA-binding domains of 60 amino acids called AP2 domains. Recently, AP2 genes have been found in the genomes of Plasmodium parasites. In P. falciparum 27 AP2-family genes have been identified. Among these genes, 26 are conserved in the other Plasmodium species whose entire genomes have been sequenced. Each member of this family has 1 to 4 AP2 domains, and the amino acid sequences of these domains are highly conserved among Plasmodium orthologs.
AP2-L encodes a protein of 1272 amino acids with two AP2 domains. These domains are located near the C-terminus of the protein and are separated from each other by a short linker.

Phenotype
Phenotype analyses of a mutant lacking expression of AP2-L (RMgm-792) indicate that the lack of expression of AP2-L does not affect blood stage and mosquito stage development. Gliding motility, cell traversal and hepatocyte invasion of sporozoites is normal. Liver stage development is strongly reduced.
Analyses of the mutant expressing a C-terminal GFP-tagged version of AP2-L showed expression and localisation of AP2-L in the nucleus of erythrocytic trophozoites, oocyst-derived sporozoites, salivary gland sporozoites and liver stages.
A mutant expressing a C-terminal tagged mCherry version of AP2-L and expressing GFP under the constitutive eef1a promoter (RMgm-794) showed mCherry-tagged AP2-L  in the nucleus of liver stages beginning at 12 hpi and rapidly increased from 24 hpi to 36 hpi with the progress of nuclear division. However, fluorescent signals completely disappeared in the large sized LS parasites at 48 hpi, suggesting that AP2-L is rapidly eliminated from the LS parasites when parasites complete schizogony.

Additional information

Other mutants
RMgm-792: A mutant lacking expression of AP2-L
RMgm-794: A mutant expressing a C-terminal tagged mCherry version of AP2-L and expressing GFP under a constitutive promoter (eef1a).


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0214400
Gene Model P. falciparum ortholog PF3D7_0730300
Gene productAP2 domain transcription factor AP2-L, putative
Gene product: Alternative nameAP2-L; ApiAP2
Details of the genetic modification
Name of the tagGFP
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid XhoI, NotI
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1aaactcgagGAAGCAAGAGATAGAGCTATTTATTGC
Additional information primer 1AP2-L-GFP 5F
Sequence Primer 2aaagctagcATCAATTTTATGGTTAACGTCGCCAG
Additional information primer 2AP2-L-GFP 5R
Sequence Primer 3aaaggatccGTGAAACGGTATAAAGGGGTGAAACAC
Additional information primer 3AP2-L-GFP 3F
Sequence Primer 4aaagcggccgcGCTTGTCCTGAGAGATATAAGGATCC
Additional information primer 4AP2-L-GFP 3R
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6